can i get glp 1 without being overweight Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford How many adults with private

The Thigh: Use the front or outer part of the thigh

Both, Byetta and Bydureon , were discontinued from the US-market in October 2024

IGF-DES IGF-DES (Insulin-like Growth Factor-1 DES(1-3)) is an ultra-potent peptide derivative of IGF-1 that offers unique advantages in muscle growth, injury repair, and cellular regeneration

Ognard J, Alipour Khabir S, Ghozy S, El Hajj G, Kallmes KM, Chen JJ, Kadirvel R, Kallmes DF, Brinjikji W

The maintenance pill The ATTAIN-MAINTAIN trial involved participants from the companys earlier SURMOUNT-5 study, which directly compared semaglutide and tirzepatide

Months 6 to 12: The SURMOUNT-5 trial published in the NEJM in 2025 found tirzepatide produced 20.2% body weight loss compared to 13.7% for semaglutide over 72 weeks in patients with obesity